Isolated Langerhans cell histiocytosis in an adult with central diabetes insipidus: Case report and review of literature

Endocrine Practice

Volumn 12, Issue 6, 2006, Pages 660-663

  Ouyang, Daniel L ^a   Roberts, Brian K ^a   Gibbs, Iris C ^a   Katznelson, Laurence ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; HISTIOCYTOSIS X; HUMAN; MALE; MIDDLE AGED; NEUROGENIC DIABETES INSIPIDUS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

DIABETES INSIPIDUS, NEUROGENIC; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 33847728705     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.6.660     Document Type: Article

References (28)

1. Sam S, Molitch ME. The pituitary mass: diagnosis and management. Rev Endocr Metab Disord. 2005;6:55-62.
2. Avery ME, McAffee JG, Guild HG. The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schüller-Christian disease and Letterer Siwe disease): a study of 40 cases. Am J Med. 1957;22:636-652.
3. Islinger RB, Kuklo TR, Owens BD, et al. Langerhans' cell histiocytosis in patients older than 21 years. Clin Orthop Relat Res. 2000;379:231-235.
4. Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (histiocytosis X) of bone: a clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995;76:2471-2484.
5. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis: a clinicopathologic study encompassing 50 years. Am J Surg Pathol. 1996;20:519-552.
6. Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:287-305.
7. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28:9-14.
8. Arico M. Langerhans cell histiocytosis in adults: more questions than answers? Eur J Cancer. 2004;40:1467-1473.
9. Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med. 2000;343:998-1007.
10. Grois N, Potschger U, Prosch H, et al. Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46:228-233.
11. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999;85:2278-2290.
12. Lin KD, Lin JD, Hsu HH, Juang JH, Huang MJ, Huang HS. Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidus. J Endocrinol Invest. 1998;21:428-433.
13. Prosch H, Grois N, Prayer D, et al. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2004;43:594-599.
14. Atchison JA, Hedlund GL, Berkow R. Diabetes insipidus and histiocytosis X: a case of isolated pituitary involvement. Endocr Pract. 1995;1:318-319.
15. Isoo A, Ueki K, Ishida T, et al. Langerhans cell histiocytosis limited to the pituitary-hypothalamic axis - two case reports. Neurol Med Chir (Tokyo). 2000;40:532-535.
16. Zornitzki T, Schattner A, Knobler H. Hypercalcemia in isolated hypothalamic-pituitary Langerhans cell histiocytosis with no bone lesions. Am J Med. 2004;117:533-534.
17. Broadbent V, Dunger DB, Yeomans E, Kendall B. Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhans cell histiocytosis and diabetes insipidus. Med Pediatr Oncol. 1993;21:649-654.
18. Modan-Moses D, Weintraub M, Meyerovitch J, Segal-Lieberman G, Bielora B. Hypopituitarism in Langerhans cell histiocytosis: seven cases and literature review. J Endocrinol Invest. 2001;24:612-617.
19. Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamopituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab. 2000;85:1370-1376.
20. Donadieu J, Rolon MA, Pion I, et al (French LCH Study Group). Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab. 2004;89:604-609.
21. Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf). 2000;53:509-515.
22. Maghnie M, Sommaruga MG, Beluffi G, Severi F. Role of MR imaging in the evaluation of the functional status of the posterior pituitary gland: the view of a pediatric endocrinologist [letter]. AJNR Am J Neuroradiol. 1993;14:1443-1445.
23. Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Arico M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood Langerhans cell histiocytosis. J Clin Endocrinol Metab. 1998;83:3089-3094.
24. Hund E, Steiner H, Jansen O, Sieverts H, Sohl G, Essig M. Treatment of cerebral Langerhans cell histiocytosis. J Neurol Sci. 1999;171:145-152.
25. Selch MT, Parker RG. Radiation therapy in the management of Langerhans cell histiocytosis. Med Pediatr Oncol. 1990;18:97-102.
26. Minehan KJ, Chen MG, Zimmerman D, Su JQ, Colby TV, Shaw EG. Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis. Int J Radiat Oncol Biol Phys. 1992;23:519-524.
27. Rosenzweig KE, Arceci RJ, Tarbell NJ. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol. 1997;29:36-40.
28. Chang SD, Main W, Martin DP, Gibbs IC, Heilbrun MP. An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system [with discussion]. Neurosurgery. 2003;52:140-147.